In our research, we retrospectively analyzed the association of 15 clinicopathological features, including 7 serum tumor markers, and the prognosis of stage I–III CRC patients after radical resection with normal preoperative CEA. The gene discussed is CEACAM5; the disease is colorectal carcinoma.